Results 231 to 240 of about 43,549 (263)
Some of the next articles are maybe not open access.
Endogenous inhibitors of lipoxygenase
European Journal of Pharmacology, 1980S A, Saeed, M, Drew, H O, Collier
openaire +2 more sources
Lipoxygenase Inhibitors and Leukotriene Receptor Antagonists
1988The object of this chapter is to give the reader an overview of the numerous agents that directly modulate the effects of the leukotriene section of the arachidonic acid cascade (Figure 8.1). These agents fall into two general categories: enzyme inhibitors and receptor antagonists.
B. J. Fitzsimmons, J. Rokach
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Lipoxygenase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999Mounting evidence suggests that lipoxygenase (LO)-catalyzed products have a profound influence on the development and progression of human cancers. Compared with normal tissues, significantly elevated levels of LO metabolites have been found in lung, prostate, breast, colon, and skin cancer cells, as well as in cells from patients with both acute and ...
V E, Steele +7 more
openaire +1 more source
5-Lipoxygenase-Inhibitors from Medicinal Plants
Planta Medica, 1986H, Wagner +3 more
openaire +2 more sources
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy
Prostaglandins, Leukotrienes and Essential Fatty Acids, 1996G, Ara, B A, Teicher
openaire +2 more sources
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly